|
Match
|
Document |
Document Title |
|
|
5834466 |
Method for protecting of heart by limiting metabolic and ionic abnormalities developed during ischemia, following ischemia or resulting from ischemia
A therapeutic and prophylactic method for protection of heart or heart tissue by limiting metabolic and ionic abnormalities developed during, following or associated with ischemia by administering...
|
|
|
5834497 |
Use of felodipine to treat cerebral dysfunction due to solvent exposure
This invention relates to the use of felodipine or a pharmaceutically acceptable salt thereof for the treatment of cerebral dysfunction due to solvent exposure.
|
|
|
5827499 |
Determining effects of psychoactive compounds on the brain using positron emission tomography
A method of determining the effects of administering a psychoactive compound, such as a drug, on a patient's brain using imaging techniques with position emission tomography (PET) is disclosed. The...
|
|
|
5798372 |
Method for preventing onset of restenosis after angioplasty employing a retinoid
A method is provided for preventing or reducing the risk of restenosis following angioplasty by administering a retinoid, such as an RAR-selective retinoid, e.g. the compound of the formula: ##STR1##
|
|
|
5798354 |
Use of adamantyl-substituted polycyclic acetylene compounds in skin and hair treatment
Novel pharmaceutically/cosmetically-active adamantyl-substituted polycyclic acetylene compounds have the structural formula (I): ##STR1## wherein Ar is a radical having one of the formulae (a)-(f):...
|
|
|
5783203 |
Insecticidal fertilizer mixtures
The present invention relates to insecticidal fertilizer mixtures comprising a fertilizer component and an agonist or antagonist of the nicotinergic acetylcholine receptors of insects.
|
|
|
5783207 |
Selectively removable nicotine-containing dosage form for use in the transmucosal delivery of nicotine
The present invention relates to a selectively removable nicotine-containing dosage form for use in the transmucosal delivery of nicotine to a patient. More specifically, the present invention is...
|
|
|
5773453 |
Methods for administration of antilipemic drugs
The present invention concerns methods for reducing cutaneous flushing in a patient to whom niacin is administered. According to the present method, two or more doses of a nonsteroidal...
|
|
|
5767136 |
1,4-Dihydropyridines useful for prevention or reduction of atherosclerotic lesions on arterial walls
The subject invention provides methods for preventing, retarding, or reducing atherosclerotic lesions or atherosclerotic degradation of aterial walls or treating atherosclerosis comprising...
|
|
|
5750108 |
Hair treatment system and kit for invigorating hair growth
A method for hair treatment is disclosed wherein a first treatment solution comprising tea tree oil is periodically applied to the scalp for at least 10 days. Then, a second treatment solution...
|
|
|
5744492 |
Method for inhibiting angiogenesis
Angiogenesis is a composite of regulated proliferation and regulated invasion occuring in a variety of normal and pathologic conditions. Compound 1 and related analogs are useful for inhibiting...
|
|
|
5739152 |
Pharmaceutical emulsion
A pharmaceutical emulsion for intravenous administration is disclosed which comprises a) a short acting dihydropyridine compound; b) a lipid phase; c) an emulsifier and d) water or a...
|
|
|
5696139 |
Use of S-enantiomers of 1,4-dihydropyridine derivatives for treating heart failure
The present invention provides S-enantiomers of 1,4-dihydropyridines useful for the treatment of heart failure, preparation of compositions thereof and a method for the treatment of hypertension...
|
|
|
5691366 |
Nitro compounds, process for preparation thereof and use thereof
A new nitro compound of the formula: ##STR1## wherein R 1 and R 2 are each lower alkyl or lower alkoxy(lower)-alkyl, or ##STR2## is cyclized to form ##STR3## X is --O--, --S-- or --NH--, m is an...
|
|
|
5679667 |
Aminoalcohols-N-Acyl derivatives as therapeutical agents against the neurogenic endoneural edema of the peripheral nerve
Aminoalcohols N-acyl derivatives useful in the prevention and in the treatment of mammalian pathologies induced by mast cell degranulation in consequence of peripheral nerve noxae.
|
|
|
5672590 |
Pharmaceutical composition for immunomodulating and adjuvant treatment
Pharmaceutical composition for immunomodulating and adjuvant therapy containing a metabolic stressor, 2-deoxy-D-ribose and further active components, i.e. ribose, DL-alanine, nicotonic acid,...
|
|
|
5665741 |
1,4-dihydropyridine-3,5-dicarboxylic acid esters in treatment of neuronal diseases
The present invention relates to the use of 1,4-dihydropyridine-3,5-dicarboxylic acid esters, some of which are known, of the general formula (I) ##STR1## in which A and R 1 -R 3 have the meaning...
|
|
|
5665740 |
Isopropyl 2-methoxyethyl 4-(2-chloro-3-cyano-phenyl)-1, 4-dihydro-2,6-dimethyl-pyridine-3,5-dica rboxylate
The present invention relates to the new compound rac-isopropyl 2-methoxyethyl 4-(2-chloro-3-cyano-phenyl)1,4 -dihydro-2,6-dimethylpyridine-3,5-dicarboxylate and its pure enantiomers, processes for...
|
|
|
5658576 |
Method for combatting cellulitis or reducing localized fatty excesses
A method for combatting cellulitis or reducing localized fatty excesses involves administering a body slimming amount of a composition which contains, as the sole slimming agent, an α-tocopherol,...
|
|
|
5658934 |
Aryl-substituted alkoxycarbonyl-1,4-dihydropyridine-5-carboxylic acid esters
The invention relates to new aryl-substituted alkoxycarbonyl-1,4-dihydropyridine-5-carboxylic acid esters, processes for their preparation and their use in medicaments, in particular as agents...
|
|
|
5650418 |
Therapeutic lysine salt composition and method of use
A therapeutic lysine-based composition and methods for its use in the prevention and treatment of cardiovascular disease is disclosed. The composition includes at least one ascorbate compound,...
|
|
|
5643960 |
Method of delaying onset of alzheimer's disease symptoms
The present invention relates, in general, to a method of preventing or delaying the onset of Alzheimer's disease and related neurodegenerative disorders. The method involves the administration to...
|
|
|
5635395 |
Optically active 1,4-dihydropyridine compounds and the microbial process for the stereoselection thereof
(4R)-3-(Substituted aminoalkyl)oxycarbonyl-1,4-dihydro-2,6-dimethyl-4-(nitrophen
yl)pyridine-5- carboxylic acids can be prepared efficiently, by reacting bis(substituted aminoalkyl)...
|
|
|
5626884 |
Treatment of sickle cell disease
A maintenance regimen with controlled intake of particular vitamin, mineral, and micronutrient formulations, drastically reduces the incidence and severity of sickle cell disease crises. The...
|
|
|
5622978 |
Pharmaceutical preparations for the oral administration of dihydropyridines in beverage form
Pharmaceutical preparations for the oral administration of dihydropyridines in beverage form are described. These preparations are characterised in that they contain a coprecipitate of essentially...
|
|
|
5618849 |
Orally active antiviral compounds
A compound represented by formula I Ar 1 --O--M--O--Ar 2 I wherein Ar 1 and Ar 2 are independently substituted phenyl or substituted pyridinyl, the...
|
|
|
5616324 |
Pro-inflammatory composition comprising at least two members of the group consisting of DL. phenylalanine, ruta graveolans and corydalis bulbosda
A synergistic mixture particularly suitable for the treatment of animals whic consists of at least two of the group consisting of DL.Phenylalanine, Ruta Graveolans and Corydali Bulbosa together...
|
|
|
5612382 |
Composition for percutaneous absorption of pharmaceutically active ingredients
A pharmaceutical composition for transdermally delivering pharmaceutically active ingredients through skin or mucosal tissues. The composition comprises pharmaceutically active ingredients in...
|
|
|
5610169 |
Pharmaceutical Composition containing slightly water-soluble drug
The orally administrable pharmaceutical compositions containing a slightly water-soluble drug, characterized by improved stability and improved absorption of the drug from digestive tract into...
|
|
|
5599824 |
Pharmaceutical preparation containing a specific crystal modification of isopropyl-(2-methoxyethyl) 1,4-dihydro-2, 6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate
The invention relates to pharmaceutical preparations, containing a specific crystal modification (subsequently called "modification II") of isopropyl-(2-methoxyethyl)...
|
|
|
5599840 |
Physiologically active and nutritional composition
A nutritional composition, adapted for consumption by mammals, contains (1) an orally ingestible diluent or carrier, except an oily carrier or diluent which comprises C 8 -18 saturated fatty acids,...
|
|
|
5594013 |
Pharmaceutical compositions containing nifedipine and process for the preparation thereof
This invention relates to a slow release nifedipine-containing pharmaceutical compositions and methods of making such compositions. The compositions of the inventions comprise a soluble carrier...
|
|
|
5593971 |
Method for preventing onset of hypertension employing a cholesterol lowering drug
A method is provided for preventing or reducing the risk of hypertension in normotensive patients having insulin resistance by administering a cholesterol lowering drug, such as pravastatin, alone...
|
|
|
5591757 |
Dihydropyridine composition
Pharmaceutical composition of certain dihydropyridine compounds and salts thereof are provided which exhibit both Ca 2 + -antagonistic and adrenergic beta-receptor blocking activities and therefore...
|
|
|
5589490 |
Benzoic acid substituted derivatives having cardiovascular activity
|
|
|
5571827 |
Methods and compositions for treating hypertension, angina and other disorders using optically pure s(-) nitrendipine
Methods and compositions are disclosed utilizing the optically pure S(-) isomer of nitrendipine. This compound is a potent drug for the treatment of hypertension while avoiding the concomitant...
|
|
|
5571794 |
Non-invasive novel method fo cosmetic lip augmentation
A cosmetic treatment for inducing upper and lower lip augmentation in humans, wherein an active ingredient encouraging vasodilatation, preferably an ultra highly diluted homeopathic, ultra highly...
|
|
|
5569458 |
Nutritional formula
A vitamin and mineral formulation which provides for improved absorption of its nutrients by the addition of digestive enzymes to the formula and including the herb goldenseal to prevent the...
|
|
|
5569678 |
Control of wound scar production
This invention pertains to a method for controlling wound scar production by administering a calcium antagonist, alone or in a combination with or followed by a steroid, to the wound site. The...
|
|
|
5559134 |
Leukotriene-B.sub.4 antagonists, process for their production and their use as pharmaceutical agents
The invention relates to leukotriene-B 4 antagonists of formula I ##STR1## in which n represents a whole number from 2 to 5, X represents a direct bond, 1 to 6 methylene units, an ortho-, meta-...
|
|
|
5559139 |
Specific 1,4-dihydropyridine-3,5-dicarboxylic acid ester, and its pharmaceutical use
The invention relates to the new dimethyl 4-(4-chloro-3-trifluoromethylphenyl) -1-cyclopropyl-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarbox
ylate, a process for its preparation and its use as a...
|
|
|
5556644 |
Nutritional supplement for the elderly
A multinutrient nutritional supplement is provided that is designed to be most effective in increasing the immunity and decreasing the instances and severity of infection particularly among older...
|
|
|
5552162 |
Method for improvement of scar size and appearance
A method for improving the size and appearance of a scar associated with a fibromatosis, a keloid, or a hypertrophic wound healing disorder comprises stimulating collagenase activity in the scar....
|
|
|
5534502 |
Process for producing fat emulsion
Stable homogeneous fatty emulsions containing amphotericin B are prepared. According to one embodiment, amphotericin B is decrystallized using an acid and ethanol and then homogeneously dispersed...
|
|
|
5530001 |
Pharmaceutical use of dihydropyridine derivative
A novel pharmaceutical use of a dihydropyridine derivative of the formula (I) ##STR1## wherein R 1 , R 2 and R 3 are the same or different and each is an alkyl or the like; R 4 is a hydrogen...
|
|
|
5525601 |
Composition for treating ocular pain
The invention relates to the use of a calcium channel blocking agent for the manufacture of a medicament for alleviatirtg pain, such as ocular pain. Particular calcium channel blocking agents that...
|
|
|
5519012 |
Inclusion complexes of optically active 1,4-dihydropyridines with methyl-β-cyclodextrin
Novel inclusion complexes of racemic 1,4-dihydropyridines and enantiomers thereof of the formula ##STR1## wherein R represents a phenyl group, substituted with nitro, trifluoromethyl,...
|
|
|
5519039 |
Composition and methods for treatment of acne vulgaris and for retardation of aging
A method and pharmaceutical composition are described for treatment of acne vulgaris which comprises administering to a patient suffering from acne vulgaris an effective amount of a pharmaceutical...
|
|
|
5508293 |
Pyridinecarboxyimidamide compounds and the use thereof
Disclosed are pyridinecarboximidamides having a vasodilating effect (hypotensive activity or antianginal activity), and acid adduct salts thereof. ##STR1## wherein when R 1 represents an alkyl,...
|
|
|
5506224 |
N-acyl derivatives of aminoalcohols active as local autacoids and useful in the therapy of autoimmune processes
N-acyl-derivatives of hydroxyamines suitable for the therapeutic treatment of pathologies characterized by degranulation of mast cells caused by a neurogenic and/or immunogenic hyperstimulation.
|